Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice

Table 1 Baseline circulating tumor cell characteristics of treatment-naïve patients with advanced pancreatic ductal adenocarcinoma according to circulating tumor cell status

Group	Patients n (%)
Number of patients with no CTC	23/107 (21.5)
Number of patients with ≥ 1 CTC	84/107 (78.5)
Number of patients with ≥ 6 CTC	55/107 (51.4)
Number of patients with E-CTCs	65/107(60.7)
Number of patients with E/M-CTCs	39/107 (36.4)
Number of patients with M-CTCs	49/107 (45.8)
CTC dynamic range
Total CTC	0-26
Median	6
E-CTC	1-11
E/M-CTC	0-26
M-CTC	0-9

CTC: Circulating tumor cells; E-CTC: Epithelial circulating tumor cells; M-CTC: Mesenchymal circulating tumor cells.